Technological progress has enabled the assessment of many physiological parameters in vivo that are highly relevant for tumour grading, tissue characterization, definition of the extent and infiltration of tumours, and planning and monitoring of therapy.
A broad range of techniques ( Table 1) provide measurements of various features of tumour blood flow and microvasculature. Increase of local blood volume and blood flow is an indicator of tumour malignancy in astrocytomas that is independent of contrast enhancement due to breakdown of the blood-brain barrier. Metabolic measurements in humans can be performed using positron emission tomography (PET) ( Table 2). [ 18 F]2-Fluoro-2-deoxy-glucose (FDG) is most widely available, but high background uptake in normal brain grey matter has to be taken into account. Increased uptake in astrocytomas (relative to normal white matter) is an indicator of malignancy and is highly correlated with reduced survival. Oligodendrogliomas typically show higher blood flow and uptake of most tracers than astrocytomas due to their high vascular and cellular density. Tracers for intermediary metabolism provide improved tumour to brain contrast. Changes in protein and DNA synthesis can be assessed through uptake of labelled amino acids and nucleosides. These advanced imaging techniques can be used to assess tumour malignancy, extent and infiltration, and might provide diagnostic clues to distinguish between lesion types and between recurrent tumour and necrosis. Stereotactic biopsies should be taken from the most malignant part of tumours, which can be identified by imaging of increased 
